Biopsy Devices – Market Insights – Europe

The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening guidelines. The market is further driven by the ongoing shift from reusable to disposable devices, and the availability of alternative technologies that further expand the patient pool is predicted to contribute to market growth over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biopsy devices in Europe from 2019 through 2033.

The introduction and implementation of updated cancer screening guidelines will support growth of the European biopsy device market.

How have the recently launched cancer screening programs impacted the market?

Which market segment will see a boom in growth due to these updated guidelines, and how?

The biopsy device market is saturated in terms of technological innovation and has seen low to moderate technological innovations over the past few years.

What are smaller players doing to grow their presence in this market?

What strategies are the bigger players adopting to stay relevant in this market?

Minimally invasive, alternative technologies to tissue biopsy are being adopted by physicians in Europe.

To what extent are physicians adopting these minimally invasive technologies?

How will the adoption of alternative technologies impact the biopsy device market?

Table of contents

Biopsy Devices - Market Insights - Europe

L. Nandini Krishna

L. Nandini Krishna is an associate healthcare research & data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate. Nandini holds a Bachelor’s degree in biomedical science from the University of Delhi, and an MBA in Hospital and Health Management from IIHMR University, Jaipur.

Contact sales Login to access report

Back to all Medtech Insights reports